These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic. Veiga FF; Gadelha MC; da Silva MRT; Costa MI; Kischkel B; de Castro-Hoshino LV; Sato F; Baesso ML; Voidaleski MF; Vasconcellos-Pontello V; Vicente VA; Bruschi ML; Negri M; Svidzinski TIE Front Microbiol; 2018; 9():779. PubMed ID: 29922236 [TBL] [Abstract][Full Text] [Related]
47. [Antimycotic therapy of Tinea unguium and other onychomycoses]. Stock I Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736 [TBL] [Abstract][Full Text] [Related]
48. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. Baran R; Hay RJ; Garduno JI J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426 [TBL] [Abstract][Full Text] [Related]
49. Tavaborole - a treatment for onychomycosis of the toenails. Gupta AK; Versteeg SG Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1145-52. PubMed ID: 27347905 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis. Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716 [TBL] [Abstract][Full Text] [Related]
51. Usefulness of histological examination for the diagnosis of onychomycosis. Gianni C; Morelli V; Cerri A; Greco C; Rossini P; Guiducci A; Braidotti P; Calcaterra R; Papini M Dermatology; 2001; 202(4):283-8. PubMed ID: 11455138 [TBL] [Abstract][Full Text] [Related]
52. Novel investigational therapies for onychomycosis: an update. Gupta AK; Studholme C Expert Opin Investig Drugs; 2016; 25(3):297-305. PubMed ID: 26765142 [TBL] [Abstract][Full Text] [Related]
54. Management of toenail onychomycosis. Tom CM; Kane MP Am J Health Syst Pharm; 1999 May; 56(9):865-71. PubMed ID: 10344609 [TBL] [Abstract][Full Text] [Related]
55. New pharmacotherapy for the treatment of onychomycosis: an update. Gupta AK; Simpson FC Expert Opin Pharmacother; 2015 Feb; 16(2):227-36. PubMed ID: 25522979 [TBL] [Abstract][Full Text] [Related]
56. Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials. Falotico JM; Lapides R; Lipner SR J Fungi (Basel); 2022 Mar; 8(3):. PubMed ID: 35330281 [TBL] [Abstract][Full Text] [Related]
57. A prospective study using image analysis to assess the efficacy of a topical treatment kit for mild onychomycosis. Khammo N; Chesters D; Goldstone L; Kennedy G; Buckley C Mycoses; 2020 Feb; 63(2):233-240. PubMed ID: 31595998 [TBL] [Abstract][Full Text] [Related]
59. Onychomycosis: burden of disease and the role of topical antifungal treatment. Daniel RC J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334 [TBL] [Abstract][Full Text] [Related]
60. [How I treat... onychomycosis by topical therapy]. Piérard GE; Piérard-Franchimont C Rev Med Liege; 2015 Jan; 70(1):5-11. PubMed ID: 25902599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]